PT-141 (Bremelanotide): Research Applications and Quality Assessment

Introduction to PT-141 (Bremelanotide)

PT-141, also known as Bremelanotide, is a synthetic melanocortin receptor agonist that has garnered significant attention in research settings. It is a cyclic heptapeptide derived from melanotan II (MT-II) and is characterized by its unique ability to influence sexual arousal independently of the vascular system, setting it apart from traditional treatments for erectile dysfunction. This compound profile will delve into the structural characteristics, mechanism of action, research applications, quality assessment, and storage of PT-141, providing researchers with a comprehensive guide for its use.

Molecular Structure and Properties

Chemical Structure

PT-141 is a cyclic peptide with the following amino acid sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂. Its molecular formula is C₅₀H₆₈N₁₄O₁₀ and its molecular weight is approximately 1025.2 g/mol. The cyclic structure, formed by a lactam bridge between the Asp and Lys residues, is crucial for its binding affinity and selectivity to melanocortin receptors.

Physical Properties

PT-141 typically presents as a white to off-white lyophilized powder. It is soluble in water and other polar solvents. The stability of PT-141 in solution is dependent on pH and temperature, with acidic pH and lower temperatures generally favoring stability. Reconstituted solutions should be used promptly or stored under specific conditions (detailed later).

Mechanism of Action

PT-141 exerts its effects by binding to and activating melanocortin receptors, primarily MC3R and MC4R, which are found in the central nervous system. Unlike PDE5 inhibitors like sildenafil (Viagra), PT-141 does not directly target the vascular system. Instead, it modulates neural pathways involved in sexual arousal. Activation of these receptors leads to a cascade of intracellular signaling events that ultimately influence sexual desire and function. The precise mechanisms by which PT-141 induces sexual arousal are still under investigation, but it is believed to involve the modulation of neurotransmitter release and neuronal activity in brain regions associated with sexual behavior.

Research Applications

PT-141's primary research focus lies in its potential to treat sexual dysfunction, particularly hypoactive sexual desire disorder (HSDD) in women and erectile dysfunction (ED) in men. Research applications include:

• Treatment of HSDD: Clinical trials have demonstrated the efficacy of PT-141 in increasing sexual desire and reducing distress associated with low sexual desire in women.
• Treatment of ED: Studies have shown that PT-141 can improve erectile function in men, particularly in those who do not respond well to PDE5 inhibitors.
• Investigation of Melanocortin Receptor Function: PT-141 serves as a valuable tool for researchers studying the physiological roles of MC3R and MC4R in various processes, including sexual function, appetite regulation, and energy homeostasis.
• Neuroscience Research: PT-141 is used to investigate the neural pathways involved in sexual behavior and motivation.

Quality Assessment of PT-141

Key Quality Markers

Ensuring the quality of PT-141 is paramount for reliable research outcomes. Several key quality markers should be assessed:

• Purity: The percentage of PT-141 in the sample. High purity is crucial to avoid confounding effects from impurities.
• Peptide Content: The actual amount of peptide present, accounting for residual water and counterions.
• Amino Acid Analysis (AAA): Verifies the correct amino acid composition and stoichiometry.
• Sequence Verification: Confirms the correct amino acid sequence.
• Moisture Content: The amount of water present in the lyophilized peptide. Excessive moisture can degrade the peptide.
• Counterion Content: The amount of counterions (e.g., acetate) present, which can affect peptide solubility and stability.
• Appearance: Should be a white to off-white lyophilized powder.
• Solubility: Should be readily soluble in water or other specified solvents.

Analytical Techniques for Quality Assessment

Several analytical techniques are employed to assess the quality of PT-141:

• High-Performance Liquid Chromatography (HPLC): Used to determine purity and identify impurities. Reverse-phase HPLC (RP-HPLC) is commonly used with UV detection at 220 nm. A purity level of ?98% is generally considered acceptable for research purposes.
• Mass Spectrometry (MS): Used to confirm the molecular weight and sequence of the peptide. Electrospray ionization mass spectrometry (ESI-MS) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) are commonly used. The observed molecular weight should match the theoretical molecular weight within a tolerance of ±1 Da.
• Amino Acid Analysis (AAA): Hydrolyzes the peptide into its constituent amino acids, which are then quantified. This technique verifies the correct amino acid composition and stoichiometry. Deviations from the expected ratios indicate potential degradation or impurities.
• Peptide Content Determination: Quantifies the actual amount of peptide present. This is typically done using UV spectrophotometry or quantitative amino acid analysis.
• Karl Fischer Titration: Measures the moisture content of the lyophilized peptide. A moisture content of ?5% is generally desired.
• Circular Dichroism (CD) Spectroscopy: Can be used to assess the secondary structure of the peptide, although this is less commonly used for routine quality control.

Interpreting Analytical Data

Interpreting the data obtained from these analytical techniques is crucial for assessing the quality of PT-141. Here's a guide:

• HPLC Purity: A single major peak should be observed in the HPLC chromatogram, with minimal peaks representing impurities. The area under the major peak represents the purity of the peptide.
• Mass Spectrometry: The observed molecular weight should match the theoretical molecular weight within an acceptable tolerance. Fragmentation patterns can also provide sequence information.
• Amino Acid Analysis: The molar ratios of the amino acids should be consistent with the peptide sequence. Significant deviations indicate potential degradation or impurities.
• Moisture Content: High moisture content can lead to peptide degradation. The Karl Fischer titration should indicate a low moisture level.

Example Data Table

Common Impurities

Several impurities can be present in PT-141 preparations. Identifying and minimizing these impurities is crucial for accurate research:

• Truncated Sequences: Peptides missing one or more amino acids.
• Deletion Sequences: Peptides with one or more amino acids deleted from the sequence.
• Modified Amino Acids: Amino acids with unwanted modifications, such as oxidation or deamidation.
• Diastereomers: Isomers with different configurations at one or more chiral centers.
• Solvents and Counterions: Residual solvents (e.g., acetonitrile, trifluoroacetic acid) and counterions (e.g., acetate) from the synthesis and purification process.

The presence of these impurities can be minimized by using high-quality starting materials, optimized synthesis and purification procedures, and rigorous quality control measures.

Storage Requirements

Proper storage is essential to maintain the stability and integrity of PT-141. The following storage conditions are recommended:

• Lyophilized Peptide: Store at -20°C or -80°C in a tightly sealed container. Protect from light and moisture. Under these conditions, the lyophilized peptide can be stable for several years.
• Reconstituted Solution: Reconstitute the peptide in sterile water or a suitable buffer. Store the solution at 2-8°C for short-term storage (up to a few days) or aliquot and store at -20°C or -80°C for long-term storage (up to several months). Avoid repeated freeze-thaw cycles.
• Solution Stability: The stability of PT-141 in solution is dependent on pH and temperature. Acidic pH (e.g., pH 4-6) generally favors stability. Consider adding a stabilizing agent, such as a protease inhibitor cocktail, to prevent degradation.

Practical Tips for Researchers

• Source from Reputable Suppliers: Choose suppliers with a proven track record of providing high-quality peptides and comprehensive analytical data. Request Certificates of Analysis (COAs) for each batch.
• Verify Purity and Identity: Perform your own quality control testing, particularly HPLC and mass spectrometry, to verify the purity and identity of the peptide.
• Handle with Care: Avoid repeated freeze-thaw cycles, which can degrade the peptide. Use sterile techniques to prevent contamination.
• Optimize Storage Conditions: Store the peptide under the recommended conditions to maximize its stability and shelf life.
• Consider Custom Synthesis: For specific research needs, consider custom peptide synthesis, which allows for greater control over the synthesis and purification process.

Key Takeaways

• PT-141 (Bremelanotide) is a melanocortin receptor agonist with research applications in sexual dysfunction.
• Quality assessment is crucial, focusing on purity (?98% by HPLC), correct molecular weight (by MS), low moisture content (?5% by Karl Fischer), and accurate amino acid composition.
• Common impurities include truncated sequences, modified amino acids, and residual solvents.
• Store lyophilized PT-141 at -20°C or -80°C, and reconstituted solutions at 2-8°C (short-term) or -20°C/-80°C (long-term) avoiding freeze-thaw cycles.
• Source from reputable suppliers and verify quality with analytical techniques like HPLC and MS.